An analysis of 22 studies found that cholesterol-lowering statins might reduce the risk of colon cancer by as much as 12%, with the greatest effect seen in the lipophilic class. The finding suggests "randomized controlled trials designed to test the hypothesis that statins reduce the risk of colorectal cancer are warranted," the lead researcher said.

Full Story:

Related Summaries